< %=imgalt%>
US Elections Calendar ~ Pervez Musharraf ~ Iftikhar Muhammad Chaudhry ~ Other International News
Home / International News / Press Releases / September 18, 2008
China Kangtai Cactus Biotech Inc. Awarded Patent for Cactus-Based Cigarette in China

Top News

Praja Rajyam Party tour programme announced

J-K police recruit 110 special police officers

Now, a range of beds that can also be banks!

Dead junkie pals pic made Cheryl Cole stay off drugs for life

RBI Governor says fundamentals of Indian economy continue to be strong

Tiger Woods vows to keep babys sex secret

Website lets netizens create a perfect candidate U.S. presidential candidate

New 2008 Edition of Times Higher-QS World University Rankings Released on October 8,2008

China Kangtai Cactus Biotech Inc. Awarded Patent for Cactus-Based Cigarette in China

Cigarette Offers Taste and Enjoyment of Nicotine with Favorable Health Profile

HARBIN, China, Sept. 18 /Xinhua-PRNewswire-FirstCall/ -- Harbin Hainan Kangda Cactus Hygienical Foods Co., Ltd. (the "Company"), a wholly-owned subsidiary of China Kangtai Cactus Bio-Tech Inc. ("China Kangtai") (OTC Bulletin Board: CKGT), announced today that it has been awarded the National Invention Patent Number 2006100102091 by the State Intellectual Property Office (SIPO) of China for Cactus Health- Preserving Cigarette.

The production of Cactus Health- Preserving Cigarettes will enhance the health of smokers throughout the country. Compared with regular cigarettes, it can lower the tar and nicotine content by 70%. In addition to reducing the harm from smoking, the honeysuckle and ginkgo biloba leaves offer medicinal benefits.

"We are excited to be awarded a patent for this revolutionary product," said Jinjiang Wang, President of China Kangtai Cactus. "We have already commenced test production runs, and believe that this product can capture a significant portion of the hundreds of millions of Chinese who are smokers."

Cactus Health- Preserving Cigarette is made from cactus and with other supplementary materials like honeysuckle, ginkgo biloba leaves and a small amount of tobacco leaves. When smokers use the product, they enjoy the taste they have come to expect from cigarettes, with substantially less tar and nicotine. It also can greatly reduce the harm to surrounding population.

The main ingredient in Cactus Health- Preserving Cigarette is dehydrated cactus palm of the famous breed of Milpa Alta edible cactus. Cactus contains many kinds of amino acid and is rich in a variety of vitamins, trace elements and many high physiological activity medical components. It is the optimal raw material for processing into health foods and inhalant. Cactus has the ability to reduce fever, detoxify and has the ability to help prevent tumors. It has strong curative effects in improving body immunity, and is very effective in curing stomatitis, phyma, skin ulcer, stomach ulcer and mumps. The other two components, honeysuckle and ginkgo biloba leaves, also have various health benefits.

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech Inc. is market-leading cactus grower and producer of cactus-related products with over 387 acres of plants and an active R&D group that holds 18 product patents and is seeking another 12 in a variety of product categories. China Kangtai's high-quality products are sold throughout China in supermarkets, food stores, hotels and restaurants through a growing distribution network that has currently covered 12 provinces and 2 municipalities.

Cautionary Statement Regarding Forward-looking Information

This press release contains forward-looking information about China Kangtai Cactus Biotech that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and China Kangtai Cactus Biotech future performance, operations and products.

    For more information, please contact:

     Chengzhi Wang
     General Manager
     China Kangtai Cactus Biotech, Inc.
     Tel:   +86-158-0451-2893
     Email: chinakangtai@gmail.com
     Web:   http://www.biocactus.com

    Investor Relations:
     Dan Schustack
     CEOcast, Inc.
     Tel:   +1-212-732-4300
     Email: dschustack@ceocast.com

SOURCE China Kangtai Cactus Bio-Tech Inc.

International News / Press Release source: PR Newswire
Copyright PR Newswire. All Rights Reserved.

International Business News / Press Releases

/C O R R E C T I O N -- China Sky One Medical, Inc./
PR Newswire

Cohen & Steers Funds Quarterly Data Now Available
PR Newswire

Galderma Announces Approval for Differin(R) Gel 0.1% in Japan
PR Newswire

Back-to-Back Top 10 Finishes for Indy Racing League Rookie Mario Moraes
PR Newswire

MutualFirst Announces Increased Second Quarter 2008 Earnings
PR Newswire

Food News / Press Releases

Back-to-Back Top 10 Finishes for Indy Racing League Rookie Mario Moraes
PR Newswire

Morton's The Steakhouse Announces Prime Recipe Contest Winner
PR Newswire

China Kangtai Cactus Biotech Inc. Launches Cactus Cattle Feed and Cactus Fish Feed
PR Newswire

American Lorain Wins Bid to Enter into Two-Year Contract with Yum! Brands
PR Newswire

CMP is Back This Year with Loads of Innovative Ideas and Varieties of Food Ingredients
PR Newswire

International Health News / Press Releases

/C O R R E C T I O N -- China Sky One Medical, Inc./
PR Newswire

Galderma Announces Approval for Differin(R) Gel 0.1% in Japan
PR Newswire

Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU
PR Newswire

Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
PR Newswire

Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock
PR Newswire